Blanket Purchase Agreement 36C24120A0093
Award Date
10/1/20
Last Date to Order
9/30/25
Federal Agency
Veterans Integrated Service Network 1
Awardee
Genmark Diagnostics, Inc.
Ultimate Awardee
Not listed
NAICS Category
325413 - In-Vitro Diagnostic Substance Manufacturing
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 19 awarded a single award blanket purchase agreement to Genmark Diagnostics, Inc. to procure diagnostic testing equipment and supplies on an as-needed basis in support of VHA medical facilities. Under the BPA, two firm fixed price call contracts were placed totaling $583,430 to provide Genmark Eplex analyzers, reagents, and other diagnostic supplies. The first call for $171,534 has a period...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 19 awarded a blanket purchase agreement to Genmark Diagnostics, Inc. for the emergency procurement of COVID-19 testing equipment and supplies. Under the terms of the BPA, the agency issued two calls valued at $112,332 and $339,898 respectively. The calls required the delivery of Genmark Analyzer systems, reagents, and related products to support coronavirus detection efforts. Place of...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 19 awarded a blanket purchase agreement to Genmark Diagnostics, Inc. to provide diagnostic equipment, reagents, and related services in support of COVID-19 testing. Under multiple firm fixed price call contracts against the BPA valued from $3,500 to approximately $661,580, Genmark will deliver Genmark analyzers, reagents, and relocation services to the place of performance in Muskogee,...
Genmark Diagnostics, Inc. was awarded a blanket purchase agreement by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 19 to provide COVID-19 diagnostic testing solutions. Under the agreement and subsequent task order calls, Genmark will deliver its ePlex molecular diagnostic systems and tests for SARS-CoV-2 to multiple locations through November 2022 with a collective value of approximately $1.8M. Delivery locations include facilities in...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 19 awarded Genmark Diagnostics, Inc. three blanket purchase agreement call contracts to procure Genmark's EPLEX molecular analyzer and COVID-19 test kits. The single award IDV has a potential value of $1,154,524 and period of performance through June 2022. Two task orders under the IDV were awarded in December 2020 and 2021 for $387,634 and $296,205.75 respectively, both requiring performance...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 19 awarded Genmark Diagnostics, Inc. two blanket purchase agreement call contracts for molecular diagnostic technologies and COVID-19 testing services. The first contract, valued at $192,516 with a completion date of December 15, 2022, was awarded on December 16, 2021 without a set-aside for the delivery of Genmark's EPLEX molecular analyzer and COVID-19 test kits to the agency location in...
The U.S. Department of Veterans Affairs (VA) awarded a Blanket Purchase Agreement (BPA) to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, to provide microbiology reagents and consumables to support the VA's clinical testing programs nationwide. The contract has a ceiling value of $23,000,000 and a period of performance through October 19, 2027. This is a single-award contract without any set-aside designations.
Under this BPA, the VA has issued several individual BPA...
This Blanket Purchase Agreement (BPA) contract was awarded by the Department of Veterans Affairs (VA) Veterans Integrated Service Network 1 (VISN 1) to Cepheid, a for-profit manufacturer of molecular diagnostic solutions. The contract has a five-year period of performance from March 2, 2023 to March 1, 2028 and a ceiling value of $1.
The purpose of this BPA is to provide the VA and affiliated healthcare facilities with Cepheid's GeneXpert diagnostic systems, associated molecular reagents,...
The Department of Veterans Affairs (VA) Veterans Integrated Service Network 19 has awarded a Blanket Purchase Agreement (BPA) to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, to provide CEPHEID REAGENTS, TEST KITS AND SUPPLIES. This single-award IDV contract has a ceiling value of $9,061,670.00 and a period of performance through September 30, 2025. The contract does not have a set-aside designation.
Under this BPA, the VA has placed several task orders for Cepheid to...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 19 awarded a blanket purchase agreement to Genmark Diagnostics, Inc. to provide emergency procurement of Genmark analyzers and reagents for COVID-19 testing. Three calls were placed against this agreement for a total value of $685,480. The calls required delivery of Genmark's diagnostic equipment and supplies to 3687 Veterans Drive in Fort Harrison, Montana to support the agency's coronavirus...